2004
DOI: 10.1016/s0025-7753(04)74224-4
|View full text |Cite
|
Sign up to set email alerts
|

Contribución de la SPECT cerebral de transportadores de dopamina en el diagnóstico diferencial de los parkinsonismos

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2010
2010
2017
2017

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 18 publications
(2 citation statements)
references
References 23 publications
0
2
0
Order By: Relevance
“…CT and MRI neuroimaging do play an important role in the diagnosis of patients with vascular parkinsonism. Radiotracer neuroimaging techniques allow to study the integrity of the dopaminergic nigrostriatal system and are therefore a valuable tool to diagnose neurodegenerative parkinsonisms (Lorenzo Bosquet et al, 2004; Tolosa et al, 2007). Positron emission tomography techniques demonstrate the disruption of selective patterns of regional cerebral metabolism and neurotransmitter systems associated with subcortical degenerations, such as Parkinson's disease, striatonigral degeneration, progressive supranuclear palsy, and corticobasal degeneration (Antonini and Isaias, 2009; Huang et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…CT and MRI neuroimaging do play an important role in the diagnosis of patients with vascular parkinsonism. Radiotracer neuroimaging techniques allow to study the integrity of the dopaminergic nigrostriatal system and are therefore a valuable tool to diagnose neurodegenerative parkinsonisms (Lorenzo Bosquet et al, 2004; Tolosa et al, 2007). Positron emission tomography techniques demonstrate the disruption of selective patterns of regional cerebral metabolism and neurotransmitter systems associated with subcortical degenerations, such as Parkinson's disease, striatonigral degeneration, progressive supranuclear palsy, and corticobasal degeneration (Antonini and Isaias, 2009; Huang et al, 2013).…”
Section: Introductionmentioning
confidence: 99%
“…Monitoring neurotransmitters level is used for assessing the nervous system function and clarifying the disease mechanisms (if any). Moreover, the detection of this class of catecholamines is of high importance in early clinical diagnosis of various neurological diseases 3 such as neuroblastomas 4 , pheochromocytomas 5 , Parkinsonism 6 , Schizophrenia 7 , Alzheimer 8 , Down’s syndrome and multiple sclerosis 9 11 .…”
Section: Introductionmentioning
confidence: 99%